MTOR and gastric cancer: Naringin can also inhibit the expression of mTOR in gastric cancer AGS cells (Raha et al., 2020), upregulate the expression of Bad, and downregulate the expression of Bcl xL, resulting in mitochondrial dysfunction, and then promote AGS apoptosis.